TY  - GEN
AU  - Sato,Hiromi
AU  - Siddig,Sana
AU  - Uzu,Miaki
AU  - Suzuki,Sayumi
AU  - Nomura,Yuki
AU  - Kashiba,Tatsuro
AU  - Gushimiyagi,Keisuke
AU  - Sekine,Yuko
AU  - Uehara,Tomoya
AU  - Arano,Yasushi
AU  - Yamaura,Katsunori
AU  - Ueno,Koichi
TI  - Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells
SN  - 1879-0712
PY  - 2015///0831
KW  - ATP Binding Cassette Transporter, Subfamily B
KW  - antagonists & inhibitors
KW  - ATP Binding Cassette Transporter, Subfamily G, Member 2
KW  - ATP-Binding Cassette Transporters
KW  - Acridines
KW  - pharmacology
KW  - Antineoplastic Agents
KW  - chemistry
KW  - Biological Transport
KW  - drug effects
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Cell Line, Tumor
KW  - Cell Survival
KW  - Drug Resistance, Multiple
KW  - Drug Resistance, Neoplasm
KW  - Drug Synergism
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Indoles
KW  - agonists
KW  - Kidney Neoplasms
KW  - Kinetics
KW  - Membrane Transport Modulators
KW  - Neoplasm Proteins
KW  - Protein Kinase Inhibitors
KW  - Pyrroles
KW  - RNA, Messenger
KW  - metabolism
KW  - Sunitinib
KW  - Tetrahydroisoquinolines
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ejphar.2014.11.021
ER  -